CMS issues proposed decision memorandum for screening for cervical cancer with testing
Physician Practice Insider, May 5, 2015
On April 16, CMS posted a proposed decision memorandum stating evidence is sufficient to add Human Papillomavirus (HPV) testing once every five years as an additional preventive service benefit under the Medicare program for asymptomatic beneficiaries aged 30 to 65 years in conjunction with the pap smear test. CMS will cover screening for cervical cancer with the appropriate FDA-approved/cleared laboratory tests, used consistent with FDA-approved labeling and in compliance with the CLIA regulations.
View the proposed decision memorandum.
This article originally appeared in Medicare Weekly Insider.
Related Products
Most Popular
- Articles
-
- FDA says to decrease reuse of devices, CMS removes some blanket waivers
- Don't forget the three checks in medication administration
- Note similarities and differences between HCPCS, CPT® codes
- Practice the six rights of medication administration
- Nursing responsibilities for managing pain
- Prevent dehydration with nursing interventions
- Q&A: Primary, principal, and secondary diagnoses
- Steps for maintaining patient privacy
- The consequences of an incomplete medical record
- Know the medical gas cylinder storage requirements
- E-mailed
-
- FDA says to decrease reuse of devices, CMS removes some blanket waivers
- Understand the spine to code back procedures correctly
- Refine the terms: Understand unbilled accounts and DNFB
- Q/A: Correct use of modifier -PT
- Q/A: Coding for wound care with no-cost skin substitute
- Q&A: Use yes/no queries to resolve surgical complication questions
- Proper coding for polyp removal
- Expirations on standing orders
- Developing a Fall-Prevention Program
- Clinically Speaking: Check CDI efforts related to functional quadriplegia
- Searched